BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38123146)

  • 1. Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma.
    Riner AN; Herremans KM; Vudatha V; Han S; Qu X; Liu J; Mukhopadhyay N; Freudenberger DC; George TJ; Judge SM; Judge AR; Hughes SJ; Trevino JG
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):149-158. PubMed ID: 38123146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy.
    Zhong X; Pons M; Poirier C; Jiang Y; Liu J; Sandusky GE; Shahda S; Nakeeb A; Schmidt CM; House MG; Ceppa EP; Zyromski NJ; Liu Y; Jiang G; Couch ME; Koniaris LG; Zimmers TA
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1083-1101. PubMed ID: 31286691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin.
    Zhong X; Narasimhan A; Silverman LM; Young AR; Shahda S; Liu S; Wan J; Liu Y; Koniaris LG; Zimmers TA
    J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2146-2161. PubMed ID: 35510530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The differential effects of sarcopenia and cachexia on overall survival for pancreatic ductal adenocarcinoma patients following pancreatectomy: A retrospective study based on a large population.
    Shen XD; Wang X; Zheng ZJ; Chen YH; Tan CL; Liu XB; Ke NW
    Cancer Med; 2023 May; 12(9):10438-10448. PubMed ID: 36938648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Sah RP; Sharma A; Nagpal S; Patlolla SH; Sharma A; Kandlakunta H; Anani V; Angom RS; Kamboj AK; Ahmed N; Mohapatra S; Vivekanandhan S; Philbrick KA; Weston A; Takahashi N; Kirkland J; Javeed N; Matveyenko A; Levy MJ; Mukhopadhyay D; Chari ST
    Gastroenterology; 2019 May; 156(6):1742-1752. PubMed ID: 30677401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of noncoding RNAs in pancreatic ductal adenocarcinoma associated cachexia.
    Uddin MH; Mohammad RM; Philip PA; Azmi AS; Muqbil I
    Am J Physiol Cell Physiol; 2022 Dec; 323(6):C1624-C1632. PubMed ID: 36280389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine.
    Gerber MH; Underwood PW; Judge SM; Delitto D; Delitto AE; Nosacka RL; DiVita BB; Thomas RM; Permuth JB; Hughes SJ; Wallet SM; Judge AR; Trevino JG
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signaling.
    Xu PC; You M; Yu SY; Luan Y; Eldani M; Caffrey TC; Grandgenett PM; O'Connell KA; Shukla SK; Kattamuri C; Hollingsworth MA; Singh PK; Thompson TB; Chung S; Kim SY
    Sci Rep; 2022 Jan; 12(1):1659. PubMed ID: 35102236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomic analysis of head and body/tail of pancreatic ductal adenocarcinoma at early and late stages.
    Zhang X; Feng S; Wang Q; Huang H; Chen R; Xie Q; Zhang W; Wang A; Zhang S; Wang L; Yao M; Ling Q
    J Cell Mol Med; 2021 Feb; 25(3):1750-1758. PubMed ID: 33452856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function.
    Bachmann J; Ketterer K; Marsch C; Fechtner K; Krakowski-Roosen H; Büchler MW; Friess H; Martignoni ME
    BMC Cancer; 2009 Jul; 9():255. PubMed ID: 19635171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer.
    Ramsey ML; Talbert E; Ahn D; Bekaii-Saab T; Badi N; Bloomston PM; Conwell DL; Cruz-Monserrate Z; Dillhoff M; Farren MR; Hinton A; Krishna SG; Lesinski GB; Mace T; Manilchuk A; Noonan A; Pawlik TM; Rajasekera PV; Schmidt C; Guttridge D; Hart PA
    Pancreatology; 2019 Jan; 19(1):80-87. PubMed ID: 30497874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
    Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
    J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Interplay Among Pancreatic Cancer, Cachexia, Body Composition, and Diabetes.
    Dunne RF; Roeland EJ
    Hematol Oncol Clin North Am; 2022 Oct; 36(5):897-910. PubMed ID: 36154783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
    Winer LK; Dhar VK; Wima K; Morris MC; Lee TC; Shah SA; Ahmad SA; Patel SH
    J Surg Res; 2019 Jul; 239():60-66. PubMed ID: 30802706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the molecular pathology of pancreatic body and tail adenocarcinoma.
    Dreyer SB; Jamieson NB; Upstill-Goddard R; Bailey PJ; McKay CJ; ; Biankin AV; Chang DK
    Br J Surg; 2018 Jan; 105(2):e183-e191. PubMed ID: 29341146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
    Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
    BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between circulating tumour DNA and skeletal muscle stores at diagnosis of pancreatic ductal adenocarcinoma: a cross-sectional study.
    Hanna L; Sellahewa R; Huggins CE; Lundy J; Croagh D
    Sci Rep; 2023 Jun; 13(1):9663. PubMed ID: 37316578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and frequency of cancer cachexia during chemotherapy for advanced pancreatic ductal adenocarcinoma.
    Mitsunaga S; Kasamatsu E; Machii K
    Support Care Cancer; 2020 Nov; 28(11):5271-5279. PubMed ID: 32103356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated malnutrition and muscle wasting.
    Dong J; Yu J; Li Z; Gao S; Wang H; Yang S; Wu L; Lan C; Zhao T; Gao C; Liu Z; Wang X; Hao J
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):704-716. PubMed ID: 33763996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia.
    Deng M; Aberle MR; van Bijnen AAJHM; van der Kroft G; Lenaerts K; Neumann UP; Wiltberger G; Schaap FG; Olde Damink SWM; Rensen SS
    Front Immunol; 2023; 14():1159411. PubMed ID: 37006254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.